They are at the pointy end I believe for CTAP, and it's all hinged of the success and current trials in place for HIV currently being trialed in the human body as we speak.
I think the FDA will be more than happy with the package that Biotron has supplied them, the main factor being that they are happy to put it into immune compromised people with HIV so will be more than happy to trial it on people with COVID, but actually think it's a "given"
Happy for anyone to give me a different view as to why it won't be excepted for CTAP???? #magicpill-$$
Ann: BIT225 Effectiveness Against COVID-19 in Animals, page-127
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
